PBM Consulting – Specialty Drug Costs
April 7, 2011
Most Popular Posts
Specialty drug costs will continue to grow and dominate a plan sponsors’ drug spend if left unchecked (expected to grow from approx. 20-25% today to 45% of drug spend by 2030). Surprisingly, as many as 50% of all Rx plan sponsors have not yet acted to implement a coordinated Specialty Drug Strategy(“SDS”). At WBC (wbcbaltimore.com) we’ve created a […]
